Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Proposing an Algorithm for the Pharmacological Management of Posttraumatic Stress Disorder

Proposing an Algorithm for the Pharmacological Management of Posttraumatic Stress Disorder The clinical management of posttraumatic stress disorder (PTSD) is as complex as the condition itself. Pharmacotherapy is an important component of this treatment process, which also includes psychosocial interventions and, in most cases, entails long-term efforts. The authors propose a systematic approach to the pharmacological treatment of PTSD using algorithmic techniques. After a careful history-taking phase and a review of available psychotropic agents, the practitioner usually ends up dealing with either PTSD alone or, more frequently, accompanied by other identifiable syndromes. Various antidepressants have demonstrated efficacy in the former, while the latter requires a management aimed at depressive, anxiety/dissociative, hypomanic/manic, or psychotic symptoms. The proposed algorithm provide guidelines for treatment issues such as medication choice, medication dose, maintenance pharmacotherapy, alternative options, and eventual outcomes. Algorithms summarize current information and suggest pharmacotherapy guidelines as a significant component of a comprehensive PTSD management program. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Clinical Psychiatry Springer Journals

Proposing an Algorithm for the Pharmacological Management of Posttraumatic Stress Disorder

Download PDF
8 pages

Loading next page...
 
/lp/springer-journals/proposing-an-algorithm-for-the-pharmacological-management-of-AZ2m1Lk0rj
Publisher
Springer Journals
Copyright
Copyright © 2000 by American Academy of Clinical Psychiatrists
Subject
Medicine & Public Health; Neurology; Psychiatry; Psychopharmacology
ISSN
1040-1237
eISSN
1573-3238
DOI
10.1023/A:1009090611519
Publisher site
See Article on Publisher Site

Abstract

The clinical management of posttraumatic stress disorder (PTSD) is as complex as the condition itself. Pharmacotherapy is an important component of this treatment process, which also includes psychosocial interventions and, in most cases, entails long-term efforts. The authors propose a systematic approach to the pharmacological treatment of PTSD using algorithmic techniques. After a careful history-taking phase and a review of available psychotropic agents, the practitioner usually ends up dealing with either PTSD alone or, more frequently, accompanied by other identifiable syndromes. Various antidepressants have demonstrated efficacy in the former, while the latter requires a management aimed at depressive, anxiety/dissociative, hypomanic/manic, or psychotic symptoms. The proposed algorithm provide guidelines for treatment issues such as medication choice, medication dose, maintenance pharmacotherapy, alternative options, and eventual outcomes. Algorithms summarize current information and suggest pharmacotherapy guidelines as a significant component of a comprehensive PTSD management program.

Journal

Annals of Clinical Psychiatry – Springer Journals

Published: Oct 8, 2004

References

  • Posttraumatic stress disorder: The history of a recent concept
    Gersons, BPR; Carlier, IDE
  • Post-traumatic stress disorder in the military veteran
    Friedman, MJ; Schnurr, PP; McDonagh-Coyle, A
  • Post-traumatic stress disorder in the general population: Findings of the Epidemiological Catchment Area Survey
    Helzer, JE; Robins, LN; McEvoy, L
  • Traumatic events and posttraumatic stress disorder in an urban population of young adults
    Breslau, N; Davis, GC; Andreski, P; Peterson, E
  • Posttraumatic stress disorder in the National Comorbidity Survey
    Kessler, RC; Sonnega, A; Bromet, E; Hughes, M; Nelson, CB
  • Fortyyear follow-up of United States prisoners of war
    Kluznik, JC; Speed, N; Van Valkenburg, C; Magraw, R
  • Comparison of successful, unsuccessful, and relapsed Vietnam veterans treated for posttraumatic stress disorder
    Perconte, ST; Griger, ML
  • Pharmacology in posttraumatic stress disorder: Historical and clinical considerations and future directions
    Davidson, JRT; Nemeroff, CB
  • The Vietnam era prisoner of war. Pre-captivity personality and the development of psychiatric illness
    Ursano, RJ
  • Pre-militaryMMPI scores as predictors of combat-related PTSD symptoms
    Schnurr, PT; Friedman, MJ; Rosenberg, SD
  • Post-traumatic stress disorder in victims of civilian trauma and criminal violence
    Davis, GC; Breslau, N
  • The post-traumatic response in children and adolescents
    Schwarz, ED; Perry, BD
  • Posttraumatic stress in immigrants from Central America and Mexico
    Cervantes, RC; Salgado de Snyder, VN; Padilla, AM
  • Trauma and Its Weight: The Study and Treatment of Posttraumatic Stress Disorder
    Parson, ER
  • Ethnocultural Aspects of Posttraumatic Stress Disorder. Issues
  • Post-traumatic stress disorder: Cross-cultural aspects
    De Silva, P
  • Dissociation and posttraumatic stress disorder in Vietnam combat veterans
    Bremner, JD; Southwick, S; Brett, E; Fontana, A; Rosenheck, R; Charney, DS
  • Phenomenology and course of psychiatric disorders associated with combat-related posttraumatic stress disorder
    Mellman, TA; Randolph, CA; Brawman-Mintzer, O; Flores, LP; Milanes, FJ
  • Posttraumatic Stress Disorder among substance users from the general population
    Cottler, LB; Compton, WM; Mager, D; Spitznagel, EL; Janca, A
  • Characterization of depression in war-related posttraumatic stress disorder
    Southwick, SM; Yehuda, R; Giller, EL
  • Positive symptoms of psychosis in posttraumatic stress disorder
    Butler, RW; Muser, KT; Sprock, J; Braff, DL
  • Comorbidity of psychiatric disorders and personality profiles of American World War II prisoners of war
    Engdahl, BE; Speed, N; Eberly, RE; Schwartz, J
  • The phenomenological and conceptual interface between borderline personality disorder and PTSD
    Gunderson, JG; Sabo, AN
  • Cascade Model: An alternative to comorbidity in the pathogenesis of PTSD
    Alarcon, RD; Glover, SG; Deering, K
  • Enhanced suppression of cortisol following dexamethasone administration in combat veterans with posttraumatic stress disorder and major depressive disorder
    Yehuda, R; Southwick, SM; Krystal, JM; Bremner, D; Charney, DS; Mason, JW
  • Psychoneuroendocrinology of posttraumatic stress disorder
    Yehuda, R
  • A 50-year prospective study of the psychological sequellae of World War II combat
    Lee, KA; Vaillant, GE; Torrey, WC; Elder, GH
  • Pharmacotherapy in the treatment of posttraumatic stress disorder
    Marshall, RD; Klein, DF
  • Psychopharmacology algorithms: Pros and cons
    Stein, DJ; Jobson, KO
  • Psychiatric algorithms for primary care
    Stein, DJ; Seedat, S; Niehaus, DJH; Emsley, RA
  • Apharmacotherapy algorithm in the treatment of posttraumatic stress disorder
    Marshall, RD; Stein, DJ; Liebowitz, MR; Yehuda, R
  • Algorithms for the pharmacotherapy of anxiety disorders in patients with chemical abuse and dependence
    Osser, DN; Renner, JA; Bayog, R
  • Traumatic Stress. From Theory to Practice
    Falsetti, SA; Resnick, HS
  • The American Psychiatric Press Textbook of Psychopharmacology
    Taylor, CB
  • Efficacy of treatments for posttraumatic stress disorder
    Solomon, SD; Gerrity, ET; Muff, AM
  • “Negative symptoms”: A cumulative trauma stress disorder?
    Stumpfer, HG
  • A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder
    Hertzberg, MA; Butterfield, MI; Feldman, ME; Beckman, JC; Sutherland, SM; Connor, KM; Davidson, JRT
  • Flashbacks and posttraumatic stress symptoms in combat veterans
    Behar, D
  • In defense of polypharmacy
    Nayak, D
  • Fluoxetine in posttraumatic stress disorder
    Van der Kolk, BA; Dreyfuss, D; Michaels, M; Shera, D; Berkowitz, R; Fisler, R; Saxe, G
  • Fluoxetine in post-traumatic stress disorder
    Connor, KM; Sutherland, SM; Tupler, LA; Malik, ML; Davidson, JRT
  • Open prospective trial of fluoxetine for posttraumatic stress disorder
    Nagy, LM; Morgan, CA; Southwick, SM; Charney, DS
  • Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder
    Marmar, CR; Schoenfeld, F; Weiss, DS; Metzler, T; Zatzick, D; Wu, R; Smiga, S; Tecott, L; Neylan, T
  • Sertraline in the treatment of rape victims with posttraumatic stress disorder
    Rothbaum, BO; Ninan, PT; Thomas, L
  • Treatment of posttraumatic stress disorder with nefazodone
    Davidson, JRT; Weisler, RN; Malik, ML; Cannor, MK
  • An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder
    Marshall, RD; Schneier, FR; Fallon, BA; Knight, CBG; Abbate, LA; Goetz, D; Campeas, R; Liebowitz, MR
  • Treatment of posttraumatic stress disorder with amitryptyline and placebo
    Davidson, J; Kudler, H; Smith, R; Mahorney, SL; Lipper, S; Hammett, E; Saunders, WB; Cavenar, JO
  • Augmentation strategies in patients with refractory depression
    Nemeroff, C
  • Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design
    Hertzberg, MA; Feldman, ME; Bechham, JC; Davidson, JRT
  • Buspirone in combat-related posttraumatic stress disorder
    Fichtner, CG; Grayton, JW
  • The use of pindolol to potentiate antidepressant medication
    Blier, P; Bergeron, R
  • The role of beta-adrenoceptor blockers in the treatment of psychiatric disorders
    Bailey, D
  • Valproate in combat-related posttraumatic stress disorder
    Fesler, FA
  • Valproate and loading in the treatment of acute mania
    Keck, PE; McElroy, SL; Tugrul, KC; Bennett, JA